Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-04-19
1995-04-18
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514562, A61K 31495, A61K 3150, A61K 31195
Patent
active
054079357
ABSTRACT:
The present invention is a pharmaceutical composition having a combination of an uricosuric agent such as probenecid or the like and an excitatory amino acid antagonist useful for treating a disease advantageously affected by treatment with an excitatory amino acid antagonist.
REFERENCES:
patent: 4812458 (1989-03-01), Honoue et al.
patent: 4889855 (1989-12-01), Jacobson et al.
CA 78:106053v, Andersson et al., 1973.
CA 86: 11703h, Walters et al, 1976.
CA 87:126928y, Domer et al., 1977.
CA 97:85942j, Loescher et al., 1982.
Dissertation of Arzu Selen (Abstract only), i-iii (1984).
Neuroscience Letters, 84 (1988) 339-344.
Neuroscience Leters, 37 (1983) 75-80.
Pharmacology 1990; 40:1-7.
Advances in Pharmacology 4:91-142 (1966).
Arch. Int. Pharmacodyn. XCVIII, No. 1 97-117 (1954).
Bull. Johns Hopkins Hospital 156:333-346 (1960).
Pharmac. Res. 7(4):411-417 (1990).
Goodman and Gilman, 8th ed. pp. 745-746 (1984).
Clinical Pharmacokinetics 6:135-151 (1981).
"The Influence of a New Benzoic Acid Derivative of the Metabolism of Paraaminosalicycic Acid (PAS) and Penicillin" as presented before the 31st Annual Session of the American College of Physicians, Boston, Apr. 1950.
Clinical Pharmacology and Therapeutics 9(3):345-349 (1968).
Acta Neurol. Scandinav. 45:253-256 (1969).
Psychopharmacologia (Berl.) 25:96-100 (1972).
The Journal of Pharmacology and Experimental Therapeutics, vol. 188, No. 1, 55-65 (1974).
Eur. J. Clin. Pharmacol. 17:223-226 (1980).
Psychopharmacology 52:35-40 (1977).
Cancer Research 40:2184-2187 (Jul. 1980).
Journal of Pharmaceutical Sciences 78(9):716-22 (Sep. 1989).
Pharmaceutical Research 7(4):332-338 (1990).
Neuroscience Letters 37:75-80 (1983).
Neuroscience Letters 84:339-344 (1988).
J. Pharmacobio-Dyn., 13:158-163 (1990).
Oldendorf, W., "Certain Aspects of Drug Distribution to Brain" pp. 103-109 (1976).
The Lancet, Jul. 20, 1985, pp. 140-143.
Choi, Dennis W., "Glutamate Neurotoxicity and Diseases of the Nervous System" pp. 623-634 (1988).
Excitatory Amino Acid Antagonists, pp. 34-53 (1988).
Journal of Pharmaceutical Sciences 71(11):1238-1241 (Nov. 1982).
Bigge Christopher F.
Johnson Graham
Taylor, Jr. Charles P.
Welty Devin F.
Ashbrook Charles W.
Cintins Marianne M.
Daignault Ronald A.
Jordan Kimberly R.
Warner-Lambert & Company
LandOfFree
Pharmaceutical composition for and a method of using a combinati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for and a method of using a combinati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for and a method of using a combinati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-67464